New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Milestone Scientific Inc.
MLSS
Shape
US Flag

AMEX

Unprofitable

EPS improving

Unprofitable

EPS improving

66M

Medical - Instruments & Supplies

Next Earning date - 12 Nov 2024

66M

Medical - Instruments & Supplies

Next Earning date - 12 Nov 2024

0.86USD
Shape0.02 ( 2.61%)
favorite-chart

Relative Strenght

10
favorite-chart

Volume Buzz

-84%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

22%

Quote Panel

Shape
Updated October 19, 2024
1W 0.94 % 1M -18.96 % 3M -1.04 % 1Y -6.63 %

Key Metrics

Shape
  • Market Cap

    66.23M


  • Shares Outstanding

    77.29M


  • Share in Float

    48.61M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    0.8569


  • Average Volume

    96678


  • Beta

    1.076


  • Range

    0.52-1.1


  • Industry

    Medical - Instruments & Supplies


  • Website

    https://www.milestonescientific.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

7.86x

P/S Ratio

8.62x

P/B Ratio

0.0

Debt/Equity

-54.9%

Net Margin

$-0.1

EPS

How MLSS compares to sector?

P/E Ratio

Relative Strength

Shape

MLSS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$11M

Shape514%

2025-Revenue

$0.04

Shape-1529%

2025-EPS

$8M

Shape-344%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Benchmark

initialise

Previous: Not converted

2024-10-10

Now: Speculative Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.03
vs -0.03

Q4.22

arrow
arrow

N/A

-0.02
vs -0.02

Q1.23

arrow
arrow

N/A

-0.02
vs -0.03

Q2.23

arrow
arrow

N/A

-0.03
vs -0.04

Q3.23

arrow
arrow

N/A

-0.02
vs -0.03

Q4.23

arrow
arrow

N/A

-0.03
vs -0.02

Q1.24

arrow
arrow

N/A

-0.02
vs -0.02

Q2.24

arrow
arrow

N/A

-0.02
vs -0.03

Q3.24

arrow
arrow

N/A

-0.01
vs -0.02

Q4.24

arrow
arrow

N/A

-0.01
vs -0.03

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+5%

2.2M  vs 2.1M

Q4.22

arrow
arrow

-21%

2.2M  vs 2.8M

Q1.23

arrow
arrow

-4%

2.6M  vs 2.7M

Q2.23

arrow
arrow

+77%

2.9M  vs 1.6M

Q3.23

arrow
arrow

-7%

2.1M  vs 2.2M

Q4.23

arrow
arrow

+1%

2.3M  vs 2.2M

Q1.24

arrow
arrow

-13%

2.2M  vs 2.6M

Q2.24

arrow
arrow

-36%

1.9M  vs 2.9M

Q3.24

arrow
arrow

+27%

2.6M  vs 2.1M

Q4.24

arrow
arrow

+28%

2.9M  vs 2.3M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-17%

-0.17
vs -0.22

Q4.22

arrow
arrow

-19%

-0.19
vs -0.17

Q1.23

arrow
arrow

-14%

-0.14
vs -0.19

Q2.23

arrow
arrow

-28%

-0.28
vs -0.14

Q3.23

arrow
arrow

-20%

-0.20
vs -0.28

Q4.23

arrow
arrow

-24%

-0.24
vs -0.20

Q1.24

arrow
arrow

-19%

-0.19
vs -0.24

Q2.24

arrow
arrow

+3%

0.03
vs -0.19

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

33

33
vs 35

-6%

Q4.22

arrow
arrow

33

33
vs 33

NA

Q1.23

arrow
arrow

26

26
vs 33

-21%

Q2.23

arrow
arrow

30

30
vs 26

15%

Q3.23

arrow
arrow

36

36
vs 30

20%

Q4.23

arrow
arrow

33

33
vs 36

-8%

Q1.24

arrow
arrow

31

31
vs 33

-6%

Q2.24

arrow
arrow

33

33
vs 31

6%

Earnings Growth

Latest News